source_paper
string
source_section
string
premise
string
target_doi
string
target_paper
string
PMC10010521
Introduction
Globally, Shigella species are a leading cause of diarrhoeal mortality, causing an estimated 200,000 deaths in 2016 [11].
10.1016/S1473-3099(18)30475-4
PMC6202441
PMC10010521
Introduction
In contrast, the highest rates of shigellosis in high-income countries typically occur through person-to-person contact in crowded communities and childcare centres, in travellers returning from overseas or in MSM [9,13].
10.1093/jpids/piab045
PMC8744073
PMC10010521
Introduction
Increasing transmission of Shigella among MSM, particularly antimicrobial resistant strains, have been reported in several high-income countries, including the United States, Canada, Germany and the United Kingdom [14–17].
10.3201/eid2302.161203
PMC5324786
PMC10010521
Introduction
The most commonly reported species in high-income countries is S. sonnei, with this species accounting for over 80% of shigellosis infections in the United States and Israel, and over 50% of infections in the United Kingdom [18–20].
10.3201/eid2806.220131
PMC9155871
PMC10010521
Introduction
The most commonly reported species in high-income countries is S. sonnei, with this species accounting for over 80% of shigellosis infections in the United States and Israel, and over 50% of infections in the United Kingdom [18–20].
10.1128/JCM.01692-19
PMC7098776
PMC10010521
Introduction
Currently, PCR assays for detecting Shigella target the invasion plasmid antigen H (ipaH) gene, which is also common to entero-invasive Escherichia coli (EIEC) [25].
10.1128/JCM.42.5.2031-2035.2004
PMC404673
PMC10010521
Discussion
While S. flexneri is traditionally linked to low and middle income countries and S. sonnei to high income countries, in recent years the expansion of S. sonnei has been documented in many economically transitional regions in Asia, Latin America and the Middle East [28].
10.1371/journal.pntd.0003708
PMC4466244
PMC10010521
Discussion
Globally, data on the epidemiology of S. boydii is limited, with this species being predominantly endemic in the Indian Subcontinent [29].
10.1093/nar/gki954
PMC1278947
PMC10010521
Discussion
S. dysenteriae serotype 1, which is the only Shigella species and serotype that expresses the Shiga toxin gene, has high epidemic potential and has been identified as a cause of several large scale outbreaks of dysentery, particularly in settings associated with civil unrest [30–34].
10.1128/AEM.69.12.7028-7031.2003
PMC310026
PMC10010521
Discussion
S. dysenteriae serotype 1, which is the only Shigella species and serotype that expresses the Shiga toxin gene, has high epidemic potential and has been identified as a cause of several large scale outbreaks of dysentery, particularly in settings associated with civil unrest [30–34].
10.3389/fcimb.2016.00045
PMC4835486
PMC10010521
Discussion
This strain is also notorious for developing drug resistance, with epidemic strains typically resistant to multiple antibiotics [35,36].
10.1128/IAI.05814-11
PMC3232646
PMC10010521
Discussion
The epidemiology of S. dysenteriae is distinct from the other species of Shigella, with epidemics tending to disappear and then reappear years later, with few sporadic cases reported in between outbreaks [37,38].
10.1186/1471-2164-15-355
PMC4038718
PMC10010521
Discussion
The epidemiology of S. dysenteriae is distinct from the other species of Shigella, with epidemics tending to disappear and then reappear years later, with few sporadic cases reported in between outbreaks [37,38].
10.3389/fcimb.2017.00064
PMC5364150
PMC10010521
Discussion
While large scale outbreaks of S. dysenteriae serotype 1 were prevalent in the second half of the twentieth century in Asia, Africa and Central America, there has been a drastic decline in the incidence of S. dysenteriae in the last few decades, which remains largely unexplained [7,34,39].
10.1007/s40475-014-0019-6
PMC4126259
PMC10010521
Discussion
While large scale outbreaks of S. dysenteriae serotype 1 were prevalent in the second half of the twentieth century in Asia, Africa and Central America, there has been a drastic decline in the incidence of S. dysenteriae in the last few decades, which remains largely unexplained [7,34,39].
10.3389/fcimb.2016.00045
PMC4835486
PMC10010521
Discussion
It is widely documented that people living in remote areas have poorer health outcomes, including higher rates of hospitalisation and death, and also have more limited access to, and use of, health care services [41,42].
10.1017/S1463423620000481
PMC7737170
PMC10010521
Discussion
Antimicrobial resistance has also been reported in endemic strains of Shigella affecting First Nations Australians [45].
10.1007/s10096-020-04029-w
PMC7473701
PMC10010521
Discussion
Overcrowding and lack of safe removal and treatment of sewage has shown to be positively associated with gastrointestinal infections in First Nations Australian households [47].
10.3390/ijerph15122827
PMC6313733
PMC10010521
Discussion
Consistent with global trends, the burden of shigellosis in Australia was highest in children aged less than five years [31,48].
10.1371/journal.pmed.0030353
PMC1564174
PMC10010521
Discussion
Additionally, the low infectious dose of Shigella results in person-to-person transmission, which often occurs between children in childcare settings through close contact [7,51].
10.1007/s40475-014-0019-6
PMC4126259
PMC10010521
Discussion
This is likely to reflect ongoing transmission among MSM in these states, with outbreaks occurring over several years in three of the most populous states (Victoria (VIC), New South Wales (NSW) and Queensland) [23,52–54].
10.1128/JCM.40.4.1538-1540.2002
PMC140385
PMC10010521
Discussion
Several studies have demonstrated the increased capability of CIDT in identifying the aetiology of diarrhoeal patients when compared to culture dependent methods, with estimates ranging from two to four times when using CIDT [58–60].
10.1016/S0140-6736(16)31529-X
PMC5471845
PMC10010521
Discussion
Several studies have demonstrated the increased capability of CIDT in identifying the aetiology of diarrhoeal patients when compared to culture dependent methods, with estimates ranging from two to four times when using CIDT [58–60].
10.3389/fmicb.2016.00386
PMC4811922
PMC10010521
Discussion
The process to obtain this information is faster as WGS does not require the application of multiple subtyping methodologies [62].
10.1128/AEM.00165-19
PMC6585509
PMC10010521
Discussion
Additionally, WGS can differentiate between Shigella and EIEC, which have many biochemical properties and virulence genes in common [62,63].
10.1128/AEM.00165-19
PMC6585509
PMC10010531
Introduction
syphilis, gonorrhoea, chlamydia, and trichomoniasis [5].
10.1371/journal.pone.0143304
PMC4672879
PMC10010531
Introduction
hepatitis B, herpes simplex virus (HSV or herpes), HIV, and human papillomavirus (HPV) [5].
10.1371/journal.pone.0143304
PMC4672879
PMC10010531
Introduction
Mother-to-child transmission of STIs has effects like stillbirth, neonatal death, low-birth weight and prematurity, sepsis, pneumonia, neonatal conjunctivitis, and congenital deformities [6].
10.2471/BLT.18.228486
PMC6653813
PMC10010531
Introduction
STIs remain a major public health challenge for people belonging to high-risk groups (for HIV) around the world [6].
10.2471/BLT.18.228486
PMC6653813
PMC10010531
Materials and methods
Inclusion of studies from Grey literature will be carried out after being checked through a quality assessment tool (Axis Tool) [14].
10.1136/bmjopen-2016-011458
PMC5168618
PMC10010531
Materials and methods
6.0) generated modified data extraction form [16].
10.1186/s12859-018-2334-8
PMC6196404
PMC10010531
Materials and methods
To evaluate publication bias Egger’s [18] and Begg and Mazumdar’s [19] assessments will be used along with the Funnel diagram.
10.1136/bmj.315.7109.629
PMC2127453
PMC10010533
Introduction
SARS-CoV-2 primarily spreads via aerosols and droplets, and the degree of aerosolization is related to multiple factors, including ventilation [1–4].
10.1016/S0140-6736(21)00869-2
PMC8049599
PMC10010533
Introduction
SARS-CoV-2 primarily spreads via aerosols and droplets, and the degree of aerosolization is related to multiple factors, including ventilation [1–4].
10.1002/ppul.25330
PMC8014227
PMC10010533
Introduction
Within the built environment, the floor is the most common location where the virus can be detected [5–9].
10.1186/s40168-021-01083-0
PMC8186369
PMC10010533
Introduction
The floor was the most common surface where the virus was detected, and this observation has been replicated in other studies [5, 6, 8].
10.1136/thoraxjnl-2021-218035
PMC8646974
PMC10010533
Introduction
conducted a study at four hospitals in Korea assessing both air and surface contamination, as well as the impact of surface cleaning on the ability to detect SARS-CoV-2 [10].
10.3346/jkms.2020.35.e332
PMC7505729
PMC10010533
Introduction
They collected 330 swabs, of which 27% were positive for SARS-CoV-2 [10].
10.3346/jkms.2020.35.e332
PMC7505729
PMC10010533
Introduction
did not conduct serial swabs surrounding the patient, it is unknown how the viral burden surrounding a patient changes over space and time [8, 10].
10.3346/jkms.2020.35.e332
PMC7505729
PMC10010533
Introduction
One single-centre study in the United States swabbed within the rooms of patients with COVID-19 to determine how severity of illness and distance from the patient’s bed affected the recovery of SARS-CoV-2 from floors and high touch surfaces [11].
10.1017/ice.2021.530
PMC8755533
PMC10010533
Introduction
The probability of detecting SARS-CoV-2 from the floor was approximately 80% and did not vary over distance, but was higher for patients with more severe disease (e.g., requiring positive pressure ventilation) [11].
10.1017/ice.2021.530
PMC8755533
PMC10010533
Methods
For this study, we considered a positive result to be a Cq less than 45, which is an accepted cut-off used for environmental surveillance of SARS-CoV-2 [12].
10.1016/j.scitotenv.2021.146749
PMC8007530
PMC10010533
Discussion
We did not evaluate whether swabbing immediately after cleaning resulted in an inability to detect SARS-COV-2; however, prior studies have done so [10, 14, 15].
10.3346/jkms.2020.35.e332
PMC7505729
PMC10010533
Discussion
We did not evaluate whether swabbing immediately after cleaning resulted in an inability to detect SARS-COV-2; however, prior studies have done so [10, 14, 15].
10.1017/ice.2020.1278
PMC7653228
PMC10010533
Discussion
We did not evaluate whether swabbing immediately after cleaning resulted in an inability to detect SARS-COV-2; however, prior studies have done so [10, 14, 15].
10.1371/journal.pone.0261365
PMC8782535
PMC10010533
Discussion
In the study by Kim et al., RNA was not detected in a room routinely cleaned by disinfectant wipes, demonstrating how cleaning removes SARS-CoV-2 from the surface; however, RNA was detected in a room sprayed with disinfectant, suggesting disinfectant sprays may not be effective in reducing exposure [10].
10.3346/jkms.2020.35.e332
PMC7505729
PMC10010533
Discussion
Thus, our ability to consistently detect the virus at increasing distances from the patient’s bed goes against the historically referenced “Six-Foot Rule” [16].
10.1073/pnas.2018995118
PMC8092463
PMC10010533
Discussion
However, a prior study observed higher rates of surface contamination with SARS-CoV-2 for patients who required high-flow oxygen or positive pressure ventilation compared to hospitalized patients with less severe illness (OR = 1.6, 95% credible interval [CrI] 1.03–1.25) [11].
10.1017/ice.2021.530
PMC8755533
PMC10010538
Introduction
Injuries continue to have significant weight on the global disease burden, and are among the main causes of morbidity and mortality in adolescents, young people and adults [2].
10.1016/S0140-6736(20)30925-9
PMC7567026
PMC10010538
Introduction
Economic analysis of the implementation of interventions to assess the results and costs of these interventions aimed at improving the health of the population are recommended [4, 8] and are used to demonstrate the disease burden in monetary terms [9–11].
10.1371/journal.pone.0234300
PMC7282655
PMC10010538
Materials and methods
To estimate the disease burden of premature mortality, measures of years of potential life lost (YPLL), years of potential productive life lost (YPPLL) and cost of productivity lost CPL were used [9, 10, 19, 20].
10.1371/journal.pone.0234300
PMC7282655
PMC10010538
Materials and methods
To estimate the disease burden of premature mortality, measures of years of potential life lost (YPLL), years of potential productive life lost (YPPLL) and cost of productivity lost CPL were used [9, 10, 19, 20].
10.1136/bmjopen-2014-005386
PMC4127933
PMC10010538
Materials and methods
These concepts estimate the average time a person would live if they did not die prematurely, taking into account the age limit (death/retirement) and the cause [9].
10.1371/journal.pone.0234300
PMC7282655
PMC10010538
Materials and methods
For this study it was assumed that the individual’s productivity did not change until retirement [9].
10.1371/journal.pone.0234300
PMC7282655
PMC10010538
Discussion
The findings of this study were similar to those reported in similar studies where the active population accounted for the largest proportion of fatal victims due to injury [26, 28].
10.2471/BLT.14.145771
PMC4431514
PMC10010538
Discussion
[33, 34] reported traffic accidents and suicides as the principal external causes of death and finally, Corassa et al.
10.1155/2020/7303897
PMC7193292
PMC10010538
Discussion
The prevalence of suicide has been associated with mental disorders and sociodemographic characteristics and aggression with socioeconomic inequalities, alcohol and drug-related harm, respectively [26, 33].
10.2471/BLT.14.145771
PMC4431514
PMC10010538
Discussion
In addition, traffic accidents were among the leading causes of death in Sub-Saharan Africa and while globally, traffic accidents, falls and interpersonal violence were identified as the leading causes of death due to injury [25, 36].
10.1136/injuryprev-2015-041616
PMC4752630
PMC10010538
Discussion
Comprehensive road safety laws and their proper enforcement could contribute to the reduction of mortality from road accidents [25, 36].
10.1136/injuryprev-2015-041616
PMC4752630
PMC10010538
Discussion
In Seychelles, drowning was the leading cause of death due to external causes [41].
10.1038/s41598-020-79228-8
PMC7746745
PMC10010538
Discussion
[41] suggested the promotion of swimming programs as a measure to reduce the risk of drowning in the population.
10.1038/s41598-020-79228-8
PMC7746745
PMC10010538
Discussion
The estimated YPLL corresponded to a total of 7,222 and, a mean of 34.2 YPLL per death, which was higher than the mean obtained in Tanzania [9] and in line with the findings from Brazil which showed that males were responsible for the highest proportion of calculated YPLL, while the age ranges from 20 to 39 were responsible for approximately 60% of YPLL [35].
10.1371/journal.pone.0234300
PMC7282655
PMC10010538
Discussion
Similar to the current study, males contributed to a higher proportion of YPLL due to injuries, and overall injuries affected the potentially productive population [10, 35, 43].
10.1136/bmjopen-2014-005386
PMC4127933
PMC10010538
Discussion
In other studies, CPL due to injury was significantly higher among men than among women [10, 48].
10.1136/bmjopen-2014-005386
PMC4127933
PMC10010538
Discussion
In other studies, CPL due to injury was significantly higher among men than among women [10, 48].
10.5334/aogh.1355
PMC6997525
PMC10010538
Discussion
[10] reported that the highest average loss per death was due to trauma, amounting to 72,571 USD/death while Davey et al.
10.1136/bmjopen-2014-005386
PMC4127933
PMC10010538
Discussion
[48] presented a mean value of approximately 2500 USD per death.
10.5334/aogh.1355
PMC6997525
PMC10010538
Discussion
Results of this study demonstrate the need to standardize the classification of injuries and this could improve current estimates of mortality from external causes and complement national and global disease burden estimates [7, 26].
10.2471/BLT.14.145771
PMC4431514
PMC10010538
Discussion
Standardization can be achieved through regular training of health professionals on current guidelines [41] and the digitization of health information systems.
10.1038/s41598-020-79228-8
PMC7746745
PMC10010538
Discussion
Available data on economic costs of diseases, shows that two main methods are used to evaluate the economic impact, namely the friction method and the human capital method, with the human capital method being the most used methodology in cost-of-disease analyses [49].
10.1007/s40258-018-0416-4
PMC6467569
PMC10011442
Methods
Data preprocessing after the defacing included linear resampling to 2 mm isotropic resolution with the intensity scaled into a range of [-1,1].
10.5195/jmla.2017.88
PMC5370619
PMC10013005
Materials and Methods
The hyperparameter tuning is in the form of a 100-iteration randomized search of a set of predefined hyperparameter distributions:{‘max_iter’: [2000],‘loss’: [‘least_squares’],‘random_state’: [42],‘early_stopping’: [True],‘learning_rate’: loguniform(0.005, 0.1),‘max_leaf_nodes’: randint(2, 10),‘min_samples_leaf’: randint(100,200)}
10.6061/clinics/2019/e477
PMC6445156
PMC10013005
Materials and Methods
‘random_state’: [42],
10.6061/clinics/2019/e477
PMC6445156
PMC10013882
Introduction
Studies in sub-Saharan Africa (SSA) suggest that only 67% of patients remain in ART programs after five years, with loss to follow-up (patients with unknown outcomes) accounting for 33% of all attrition [1].
10.1002/jia2.25084
PMC5897849
PMC10013882
Introduction
DSD models aim to improve long-term ART retention by removing barriers to care, making service delivery more patient-centered [2], generate greater patient satisfaction, reduce costs to patients (and to providers in some cases), and create efficient and convenient service delivery [3].
10.1097/QAI.0000000000002070
PMC6625870
PMC10013882
Introduction
DSD models differ from conventional HIV care in the location of service delivery, frequency of interactions with the healthcare system, cadre of provider involved, and/or types of services provided [4].
10.1111/tmi.12460
PMC4670701
PMC10013882
Introduction
The attractiveness of DSD models is generally considered to be conditional on maintaining at least equivalent clinical outcomes to conventional care, but there remains relatively little evidence on ART retention among patients enrolled in DSD models as part of large-scale routine care in SSA [5, 6].
10.1186/s12889-021-11053-8
PMC8194040
PMC10013882
Introduction
The attractiveness of DSD models is generally considered to be conditional on maintaining at least equivalent clinical outcomes to conventional care, but there remains relatively little evidence on ART retention among patients enrolled in DSD models as part of large-scale routine care in SSA [5, 6].
10.1002/jia2.25640
PMC7696000
PMC10013882
Introduction
Zambia, a high-HIV burden country with more than 1.5 million people living with HIV and more than 81% of those individuals on ART, has rapidly scaled up a variety of DSD models [7].
10.1002/jia2.25808
PMC8554218
PMC10013882
Methods
The SmartCare database covers approximately three-quarters of all ART patients in Zambia, with the remainder accessing care at clinics that do not utilize the system [11].
10.1136/bmjopen-2019-030428
PMC6731929
PMC10013882
Methods
Source: Table modified from [6]
10.1002/jia2.25640
PMC7696000
PMC10013882
Discussion
Our findings are generally consistent with those of other studies of DSD model outcomes in SSA [5].
10.1186/s12889-021-11053-8
PMC8194040
PMC10013882
Discussion
Previous studies found high retention of patients in adherence clubs and home-based care models in South Africa and Kenya, among other countries [13, 14].
10.1371/journal.pmed.1002874
PMC6650049
PMC10013882
Discussion
Previous studies found high retention of patients in adherence clubs and home-based care models in South Africa and Kenya, among other countries [13, 14].
10.1097/QAI.0000000000002634
PMC8126486
PMC10013882
Discussion
Studies in Zambia have showed that DSD models achieve comparable or better outcomes than conventional care [15, 16].
10.1097/QAD.0000000000002737
PMC7810408
PMC10013882
Discussion
Studies in Zambia have showed that DSD models achieve comparable or better outcomes than conventional care [15, 16].
10.1371/journal.pmed.1003116
PMC7329062
PMC10013882
Discussion
In ART programs in SSA, males have traditionally been at higher risk of attrition than females [17], but we found that rural males in most DSD models in Zambia were retained in care as well as or relatively better than females in the same models and settings.
10.1371/journal.pone.0246471
PMC7861356
PMC10013882
Discussion
Other studies have also suggested that while DSD models may not improve retention among currently eligible patients, who are already “stable” at the time of DSD model enrollment and thus likely to continue to demonstrate high retention, it can still offer other benefits to patients and providers by reducing costs and improving quality [18, 19].
10.12688/gatesopenres.13458.2
PMC8907143
PMC10013882
Discussion
Similarly, the same model may be assigned to different dispensing intervals for a slightly different population of patients [14].
10.1097/QAI.0000000000002634
PMC8126486
PMC10013922
Introduction
Streptococcus agalactiae, commonly known as Group B Streptococcus (GBS), is an important bacterial pathogen causing morbidity and mortality in pregnant women and their babies and is also increasingly recognised as a cause of disease in nonpregnant adults [1–3].
10.1016/S2214-109X(22)00093-6
PMC9090904
PMC10013922
Introduction
Streptococcus agalactiae, commonly known as Group B Streptococcus (GBS), is an important bacterial pathogen causing morbidity and mortality in pregnant women and their babies and is also increasingly recognised as a cause of disease in nonpregnant adults [1–3].
10.1093/cid/cix664
PMC5849940
PMC10013922
Introduction
In 2020, an estimated 20 million pregnant women globally were colonised with GBS resulting in 231,000 (114,000 to 455,000) cases of EOGBS and a further 162,000 (70,000 to 394,000) LOGBS cases [1].
10.1016/S2214-109X(22)00093-6
PMC9090904
PMC10013922
Introduction
Furthermore, survivors of iGBS are at risk of long-term neurological sequelae with an estimated 37,000 (14,000 to 96,000) surviving infants developing moderate or severe neurodevelopmental impairment (NDI) [1,4].
10.1016/S2214-109X(22)00093-6
PMC9090904
PMC10013922
Introduction
Furthermore, survivors of iGBS are at risk of long-term neurological sequelae with an estimated 37,000 (14,000 to 96,000) surviving infants developing moderate or severe neurodevelopmental impairment (NDI) [1,4].
10.1016/j.eclinm.2022.101358
PMC9142788
PMC10013922
Introduction
Many higher-income countries have reduced EOGBS incidence through IAP with eligible pregnant women identified either through risk factor–based screening or routine testing based on microbiological culture [5].
10.1093/cid/cix654
PMC5850619
PMC10013922
Introduction
In addition, the need for access to laboratory testing for microbiological screening–based strategies and the requirement to deliver antibiotics intravenously substantially limits the prospect of attaining high IAP coverage in many low-resource settings where the burden of iGBS is highest [5].
10.1093/cid/cix654
PMC5850619
PMC10013922
Introduction
There are also concerns that routine administration of antibiotics could contribute to antimicrobial resistance and might also have unintended impacts on the gut microbiota of newborns [6].
10.3389/fped.2018.00027
PMC5827363
PMC10013922
Introduction
In 2015, development of a maternal vaccine against GBS was identified as a priority by the WHO Product Development for Vaccines Advisory Committee (PDVAC) [9], and 3 GBS maternal vaccine candidates have progressed to Phase II clinical trials [10].
10.1016/j.vaccine.2017.09.087
PMC6892248
PMC10013922
Introduction
In 2015, development of a maternal vaccine against GBS was identified as a priority by the WHO Product Development for Vaccines Advisory Committee (PDVAC) [9], and 3 GBS maternal vaccine candidates have progressed to Phase II clinical trials [10].
10.2147/IDR.S203454
PMC7196769
PMC10013922
Introduction
There have been previous economic evaluations of maternal GBS vaccination in the United States [12–14], Europe [15–17], and sub-Saharan Africa [18–20].
10.1136/bmj.39325.681806.AD
PMC1995477